Results 211 to 220 of about 19,758,671 (409)

Beyond the numbers: describing care at the end of life. [PDF]

PLoS Medicine, 2012
PLoS Medicine Editors
doaj   +1 more source

Ethno medicines used for treatment of prostatic disease in Foumban, Cameroon

, 2010
Emmanuel Noumi
openalex   +2 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy. [PDF]

Mol Psychiatry
Lemke JR, Eoli A, Krey I, Popp B, Strehlow V, Wittekind DA, Vuorinen AL, Aldhalaan HM, Baer S, de Saint Martin A, Hammer TB, Herman I, Hornemann F, Ingebrigtsen T, Lederer D, Lesca G, Marafie D, Mathot M, Rosenfeld JA, Møller RS, Schelhaas HJ, Stillman C, Orsini A, Patel AD, Piard J, Veggiotti P, Vlaskamp DRM, Weckhuysen S, Traynelis SF, Benke TA, Heyne HO, Syrbe S.   +31 more
europepmc   +1 more source

Halloween Open House, Vol.5 (6) November - December 2007 [PDF]

, 2007
Houston Academy of Medicine-Texas Medical Center Library
core   +1 more source

How is WHO responding to global public health threats? [PDF]

PLoS Medicine, 2007
PLoS Medicine Editors
doaj   +1 more source

Consensus paper on the use of BIVA (Bioeletrical Impendance Vector Analysis) in medicine for the management of body hydration

, 2011
Salvatore Di Somma, Henry C. Lukaski, Marta Codognotto, W. Frank Peacock, Fulvio Fiorini, Nadia Aspromonte, Claudio Ronco, Simona Santarelli, Irene Lalle, A Autunno, Antonio Piccoli   +10 more
openalex   +2 more sources

Precision medicine

Brazilian Journal of Otorhinolaryngology, 2018
openaire   +3 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Darwin 2009 Houston Events; May 7 Nurses Celebration [PDF]

, 2009
Houston Academy of Medicine-Texas Medical Center Library
core   +1 more source